Yann Mazabraud - Net Worth and Insider Trading
Yann Mazabraud Net Worth
The estimated net worth of Yann Mazabraud is at least $1 Million dollars as of 2024-09-20. Yann Mazabraud is the EVP, Head of International of Rhythm Pharmaceuticals Inc and owns about 24,495 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $1 Million. Details can be seen in Yann Mazabraud's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yann Mazabraud has not made any transactions after 2024-03-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yann Mazabraud
Yann Mazabraud Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yann Mazabraud owns 2 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) , and Trevi Therapeutics Inc (TRVI) .
Click here to see the complete history of Yann Mazabraud’s form 4 insider trades.
Insider Ownership Summary of Yann Mazabraud
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals Inc | 2024-03-19 | EVP & Head of International |
| TRVI | Trevi Therapeutics Inc | 2019-05-07 | See Remarks |
Yann Mazabraud Latest Holdings Summary
Yann Mazabraud currently owns a total of 1 stock. Yann Mazabraud owns 24,495 shares of Rhythm Pharmaceuticals Inc (RYTM) as of March 19, 2024, with a value of $1 Million.
Latest Holdings of Yann Mazabraud
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals Inc | 2024-03-19 | 24,495 | 53.15 | 1,301,909 |
Holding Weightings of Yann Mazabraud
Yann Mazabraud Form 4 Trading Tracker
According to the SEC Form 4 filings, Yann Mazabraud has made a total of 6 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Rhythm Pharmaceuticals Inc is the sale of 16,000 shares on March 19, 2024, which brought Yann Mazabraud around $627,520.
Insider Trading History of Yann Mazabraud
- 1
Yann Mazabraud Trading Performance
Yann Mazabraud Ownership Network
Yann Mazabraud Owned Company Details
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Yann Mazabraud is the EVP & Head of International of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Yann Mazabraud made 2 insider transaction in Rhythm Pharmaceuticals Inc (RYTM) with a net sale of 18,551. Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 78,894 shares made by Jennifer Chien , and a net sale of 75,787 shares made by Pamela J. Cramer .
In summary, during the past 3 months, insiders sold 191,981 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 191,981 shares. During the past 18 months, 583,578 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 583,578 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
Yann Mazabraud Mailing Address
Above is the net worth, insider trading, and ownership report for Yann Mazabraud. You might contact Yann Mazabraud via mailing address: C/o Trevi Therapeutics, Inc., 195 Church Street, Floor 14, New Haven Ct 06510.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
